Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...

The pharmacological advantages of rivaroxaban and the favorable results ... was utilized in the production of this manuscript. Atrial fibrillation (AF) is the most common cardiac arrhythmia ...

whether Afib patients with a low risk of stroke -- a group without an existing indication for anticoagulation -- were assigned lower-dose rivaroxaban (Xarelto) or placebo (7% vs 6.4%, HR 1.10 ...

A recent study published in JAMA has raised concerns about the safety of certain blood pressure medications for patients with ...